Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis
Although biologic therapies have changed the course of rheumatoid arthritis (RA), today’s major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA. Our s...
Saved in:
Main Authors: | Isabelle Duroux-Richard, Yves-Marie Pers, Sylvie Fabre, Meryem Ammari, Dominique Baeten, Guillaume Cartron, Isabelle Touitou, Christian Jorgensen, Florence Apparailly |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/342524 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin
by: Olfa Khalifa, et al.
Published: (2017-01-01) -
Les pérégrinations de Saint-Philibert. Genèse d’un réseau monastique dans la société carolingienne
by: Isabelle Cartron
Published: (2010-10-01) -
miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
by: Dina Salem Fotoh, et al.
Published: (2020-01-01) -
Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India
by: Keerthi Talari, et al.
Published: (2021-01-01) -
Exosomal miRNAs involvement in pathogenesis, diagnosis, and treatment of rheumatoid arthritis
by: Mahvash Sadeghi, et al.
Published: (2025-01-01)